Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04248283
NA

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

Sponsor: Uromedica

View on ClinicalTrials.gov

Summary

A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.

Official title: A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency

Key Details

Gender

FEMALE

Age Range

22 Years - Any

Study Type

INTERVENTIONAL

Enrollment

167

Start Date

2021-01-26

Completion Date

2025-12-30

Last Updated

2024-07-23

Healthy Volunteers

No

Interventions

DEVICE

Adjustable Continence Therapy for Women (ACT)

Two ACT devices are implanted in each patient. The devices are intended for implantation in the paraurethral space, with the balloons located on each side of the urethra near the bladder neck. The ports are placed subcutaneously in the labia majora. The balloons are filled after implantation with an isotonic solution via needle injection into the port. The ACT implant can be placed using local, spinal or general anesthesia with the surgical instruments (provided separately).

Locations (2)

University of Colorado

Denver, Colorado, United States

CHI Health Research Center

Omaha, Nebraska, United States